Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Case report

Mycobacterium fortuitum as a cause of peritoneal dialysis-associated peritonitis: case report and review of the literature

Authors: Simon H Jiang, Darren M Roberts, Andrew H Dawson, Meg Jardine

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

Peritoneal dialysis-associated peritonitis (PD-peritonitis) due to Mycobacterium spp is uncommon. Non-tuberculous Mycobacterium (NTB) PD-peritonitis can present in a similar fashion to more common causes of bacterial PD-peritonitis. We describe the first reported case of multiresistant Mycobacterium fortuitum PD-peritonitis in an Australian patient.

Case presentation

A 38 year-old woman developed mild PD-peritonitis during an overseas holiday. Treatment was complicated by delayed diagnosis, requirement for special investigations, treatment with multiple antibiotics, and conversion to haemodialysis following removal of her Tenckhoff catheter.

Conclusion

This case demonstrates the diagnostic yield of pursuing further investigations in cases of initially culture-negative, problematic PD-peritonitis. A systematic review of the literature identified only 17 reports of M. fortuitum PD-peritonitis. Similar to our case, a delay in microbiological diagnosis was frequently noted and the Tenckhoff catheter was commonly removed at the time of diagnosis. The type and duration of antibiotic therapy also varied widely so the optimum treatment appears to be poorly defined.
Appendix
Available only for authorised users
Literature
1.
go back to reference LaRocco MT, Mortensen JE, Robinson A: Mycobacterium fortuitum peritonitis in a patient undergoing chronic peritoneal dialysis. Diagn Microbiol Infect Dis. 1986, 4 (2): 161-164. 10.1016/0732-8893(86)90151-3.CrossRefPubMed LaRocco MT, Mortensen JE, Robinson A: Mycobacterium fortuitum peritonitis in a patient undergoing chronic peritoneal dialysis. Diagn Microbiol Infect Dis. 1986, 4 (2): 161-164. 10.1016/0732-8893(86)90151-3.CrossRefPubMed
2.
go back to reference Pulliam JP, Vernon DD, Alexander SR, et al: Nontuberculous mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1983, 2 (6): 610-614.CrossRefPubMed Pulliam JP, Vernon DD, Alexander SR, et al: Nontuberculous mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1983, 2 (6): 610-614.CrossRefPubMed
3.
go back to reference Kolmos HJ, Brahm M, Bruun B: Peritonitis with Mycobacterium fortuitum in a patient on continuous ambulatory peritoneal dialysis. Scand J Infect Dis. 1992, 24 (6): 801-803. 10.3109/00365549209062468.CrossRefPubMed Kolmos HJ, Brahm M, Bruun B: Peritonitis with Mycobacterium fortuitum in a patient on continuous ambulatory peritoneal dialysis. Scand J Infect Dis. 1992, 24 (6): 801-803. 10.3109/00365549209062468.CrossRefPubMed
4.
go back to reference Woods GL, Hall GS, Schreiber MJ: Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1986, 23 (4): 786-788.PubMedPubMedCentral Woods GL, Hall GS, Schreiber MJ: Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1986, 23 (4): 786-788.PubMedPubMedCentral
5.
go back to reference Tang S, Tang AW, Lam WO, et al: Successful treatment of Mycobacterium fortuitum peritonitis without Tenckhoff catheter removal in CAPD. Perit Dial Int. 2003, 23 (3): 304-305.PubMed Tang S, Tang AW, Lam WO, et al: Successful treatment of Mycobacterium fortuitum peritonitis without Tenckhoff catheter removal in CAPD. Perit Dial Int. 2003, 23 (3): 304-305.PubMed
6.
go back to reference Choi CW, Cha DR, Kwon YJ, et al: Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. Korean J Intern Med. 1993, 8 (1): 25-27.CrossRefPubMedPubMedCentral Choi CW, Cha DR, Kwon YJ, et al: Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. Korean J Intern Med. 1993, 8 (1): 25-27.CrossRefPubMedPubMedCentral
7.
go back to reference White R, Abreo K, Flanagan R, et al: Nontuberculous mycobacterial infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 1993, 22 (4): 581-587.CrossRefPubMed White R, Abreo K, Flanagan R, et al: Nontuberculous mycobacterial infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 1993, 22 (4): 581-587.CrossRefPubMed
8.
go back to reference Soriano F, Rodriguez-Tudela JL, Gomez-Garces JL, et al: Two possibly related cases of Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis. 1989, 8 (10): 895-897. 10.1007/BF01963778.CrossRefPubMed Soriano F, Rodriguez-Tudela JL, Gomez-Garces JL, et al: Two possibly related cases of Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis. 1989, 8 (10): 895-897. 10.1007/BF01963778.CrossRefPubMed
9.
go back to reference Vera G, Lew SQ: Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis. Am J Nephrol. 1999, 19 (5): 586-589. 10.1159/000013524.CrossRefPubMed Vera G, Lew SQ: Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis. Am J Nephrol. 1999, 19 (5): 586-589. 10.1159/000013524.CrossRefPubMed
10.
go back to reference Youmbissi JT, Malik QT, Ajit SK, et al: Non tuberculous mycobacterium peritonitis in continuous ambulatory peritoneal dialysis. J Nephrol. 2001, 14 (2): 132-135.PubMed Youmbissi JT, Malik QT, Ajit SK, et al: Non tuberculous mycobacterium peritonitis in continuous ambulatory peritoneal dialysis. J Nephrol. 2001, 14 (2): 132-135.PubMed
11.
go back to reference Dunmire RB, Breyer JA: Nontuberculous mycobacterial peritonitis during continuous ambulatory peritoneal dialysis: case report and review of diagnostic and therapeutic strategies. Am J Kidney Dis. 1991, 18 (1): 126-130.CrossRefPubMed Dunmire RB, Breyer JA: Nontuberculous mycobacterial peritonitis during continuous ambulatory peritoneal dialysis: case report and review of diagnostic and therapeutic strategies. Am J Kidney Dis. 1991, 18 (1): 126-130.CrossRefPubMed
12.
go back to reference Hod T, Kushnir R, Paitan Y, et al: Mycobacterium fortuitum infection in continuous ambulatory peritoneal dialysis. Clin Nephrol. 2008, 70 (6): 546-553.CrossRefPubMed Hod T, Kushnir R, Paitan Y, et al: Mycobacterium fortuitum infection in continuous ambulatory peritoneal dialysis. Clin Nephrol. 2008, 70 (6): 546-553.CrossRefPubMed
13.
go back to reference Kawamoto S, Otani K, Kawaguchi Y, et al: Mycobacterium fortuitum peritonitis associated with CAPD: diagnosis by a molecular biology technique. Perit Dial Int. 1999, 19 (6): 592-593.PubMed Kawamoto S, Otani K, Kawaguchi Y, et al: Mycobacterium fortuitum peritonitis associated with CAPD: diagnosis by a molecular biology technique. Perit Dial Int. 1999, 19 (6): 592-593.PubMed
14.
go back to reference Renaud CJ, Subramanian S, Tambyah PA, et al: The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: a case series and literature review. Nephrology. 2011, 16 (2): 174-179. 10.1111/j.1440-1797.2010.01370.x.CrossRefPubMed Renaud CJ, Subramanian S, Tambyah PA, et al: The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: a case series and literature review. Nephrology. 2011, 16 (2): 174-179. 10.1111/j.1440-1797.2010.01370.x.CrossRefPubMed
15.
go back to reference Linton IM, Leahy SI, Thomas GW: Mycobacterium gastri peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. Aust N Z J Med. 1986, 16 (2): 224-225. 10.1111/j.1445-5994.1986.tb01155.x.CrossRefPubMed Linton IM, Leahy SI, Thomas GW: Mycobacterium gastri peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. Aust N Z J Med. 1986, 16 (2): 224-225. 10.1111/j.1445-5994.1986.tb01155.x.CrossRefPubMed
16.
go back to reference Jiang SH, Senanayake S, Talaulikar GS: Peritoneal dialysis-related peritonitis due to Mycobacterium smegmatis. Perit Dial Int. 2011, 31 (2): 215-216.PubMed Jiang SH, Senanayake S, Talaulikar GS: Peritoneal dialysis-related peritonitis due to Mycobacterium smegmatis. Perit Dial Int. 2011, 31 (2): 215-216.PubMed
17.
go back to reference Fahim M, Hawley CM, McDonald SP, et al: Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis. 2010, 55 (4): 690-697. 10.1053/j.ajkd.2009.11.015.CrossRefPubMed Fahim M, Hawley CM, McDonald SP, et al: Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis. 2010, 55 (4): 690-697. 10.1053/j.ajkd.2009.11.015.CrossRefPubMed
18.
go back to reference Li PK, Szeto CC, Piraino B, et al: Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010, 30 (4): 393-423. 10.3747/pdi.2010.00049.CrossRefPubMed Li PK, Szeto CC, Piraino B, et al: Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010, 30 (4): 393-423. 10.3747/pdi.2010.00049.CrossRefPubMed
Metadata
Title
Mycobacterium fortuitum as a cause of peritoneal dialysis-associated peritonitis: case report and review of the literature
Authors
Simon H Jiang
Darren M Roberts
Andrew H Dawson
Meg Jardine
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-35

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.